SCHEMBL4042441

SCHEMBL4042441

CC(=O)OC(=O)C1C(N)CCN1C(=O)OCC1c2ccccc2-c2ccccc21

nearest known ligand 0.40

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.40
FABP5 Q01469 3/20 0.39
FABP7 O15540 2/20 0.39
PIN1 Q13526 1/20 0.36
EPHX2 P34913 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
POLB P06746 1/20 0.35
F2 P00734 1/20 0.34
OPRD1 P41143 1/20 0.34
CASP3 P42574 1/20 0.33
PARP1 P09874 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5941730 1.00 KMT2A (0.40) KMT2AFABP5FABP7PIN1EPHX2
Acetic Acid SCHEMBL5941723 0.87 FABP5 (0.43) KMT2AFABP5FABP7PIN1EPHX2
Acetic Acid SCHEMBL4042425 0.87 FABP5 (0.43) KMT2AFABP5FABP7PIN1EPHX2
SCHEMBL4040012 0.85 FABP5 (0.45) KMT2AFABP5FABP7EPHX2CA1
SCHEMBL16179303 0.77 KMT2A (0.45) KMT2AFABP5FABP7EPHX2OPRD1
SCHEMBL4050272 0.76 FABP5 (0.47) KMT2AFABP5FABP7EPHX2CA1
SCHEMBL3423135 0.76 FABP5 (0.47) KMT2AFABP5FABP7EPHX2CA1
SCHEMBL30686169 0.76 FABP5 (0.47) KMT2AFABP5FABP7EPHX2CA1
SCHEMBL30686135 0.76 FABP5 (0.47) KMT2AFABP5FABP7EPHX2CA1
SCHEMBL4448418 0.76 FABP5 (0.47) KMT2AFABP5FABP7EPHX2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546150-B1 PYRROLE DERIVATIVES AS INHIBITORS OF CYTEINE PROTEASES AMURA THERAPEUTICS LTD (GB) 2009-03-04 EP disclosed
CN-100354276-C Biologically active compounds AMURA THERAPEUTICS LTD (GB) 2007-12-12 CN disclosed
CN-1681817-A Biologically active compounds AMURA THERAPEUTICS LTD (GB) 2005-10-12 CN disclosed
EP-1546150-A1 BIOLOGICALLY ACTIVE COMPOUNDS Amura Therapeutics Limited (GB) 2005-06-29 EP disclosed
WO-2004007501-A1 BIOLOGICALLY ACTIVE COMPOUNDS AMURA THERAPEUTICS LIMITED (GB) 2004-01-22 WO disclosed